Related Experiment Video
Updated: Oct 19, 2025

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Computational Analysis of Binding Interactions between the Ryanodine Receptor Type 2 and Calmodulin
D'Artagnan Greene1, Michael Barton1, Tyler Luchko1
1Department of Physics, California State University, Northridge, California 91330, United States.
Abstract:
Mutations in the cardiac ryanodine receptor type 2 (RyR2) have been linked to a variety of cardiac arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). RyR2 is regulated by calmodulin (CaM), and mutations that disrupt their interaction can cause aberrant calcium release, leading to an arrhythmia. It was recently shown that increasing the RyR2-CaM binding affinity could rescue a defective CPVT-related RyR2 channel to near wild-type behavior. However, the interactions that determine the binding affinity at the RyR2-CaM binding interface are not well understood. In this study, we identify the key domains and interactions, including several new interactions, involved in the binding of CaM to RyR2. Also, our comparison between the wild-type and V3599K mutant suggests how the RyR2-CaM binding affinity can be increased via a change in the central and N-terminal lobe binding contacts for CaM. This computational approach provides new insights into the effect of a mutation at the RyR2-CaM binding interface, and it may find utility in drug design for the future treatment of cardiac arrhythmias.
Insights
Mutations in cardiac ryanodine receptor type 2 (RyR2) cause arrhythmias. This study identifies key RyR2-calmodulin interactions, revealing how mutations can increase binding affinity to potentially treat cardiac conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biophysics
Background:
- Mutations in cardiac ryanodine receptor type 2 (RyR2) are associated with cardiac arrhythmias like catecholaminergic polymorphic ventricular tachycardia (CPVT).
- RyR2 function is modulated by calmodulin (CaM); disrupted RyR2-CaM interaction leads to abnormal calcium release and arrhythmias.
- Enhancing RyR2-CaM binding affinity has shown potential in rescuing CPVT-related RyR2 channel function.
Purpose of the Study:
- To elucidate the specific interactions governing calmodulin binding to RyR2.
- To understand how mutations at the RyR2-CaM interface affect binding affinity.
- To provide insights for potential therapeutic strategies targeting RyR2-CaM interactions.
Main Methods:
- Computational analysis of RyR2-CaM binding interfaces.
- Identification of key interaction domains and novel binding sites.
- Comparative analysis of wild-type RyR2 and a V3599K mutant.
Main Results:
- Key domains and several previously unidentified interactions critical for CaM binding to RyR2 were identified.
- The study suggests that altering CaM's binding contacts in the central and N-terminal lobes can enhance RyR2-CaM binding affinity.
- The V3599K mutation provides a model for understanding how affinity can be modulated.
Conclusions:
- This research clarifies the molecular basis of RyR2-CaM interaction and the impact of mutations.
- The findings offer a computational basis for designing drugs to modulate RyR2-CaM binding.
- This work contributes to developing novel treatments for cardiac arrhythmias by targeting RyR2 function.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
The Equilibrium Binding Constant and Binding Strength

